Last reviewed · How we verify
trigger point injection
At a glance
| Generic name | trigger point injection |
|---|---|
| Sponsor | Samsung Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study
- Comparison of the Effectiveness of Dry Needling Versus the Combination of Dry Needling and Local Anesthetic Injection in Myofascial Pain Syndrome of the Upper Trapezius Muscle: A Sham-Controlled, Randomized Clinical Trial (PHASE4)
- Comparison of Dry Needling and Two Botulinum Toxins for Bruxism (NA)
- Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial (PHASE2, PHASE3)
- VCOM Pain Free Research Collaborative (NA)
- Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department (PHASE4)
- Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty (PHASE2)
- Magnesium Sulfate as an Adjuvant to Lidocaine in MPDS Trigger Point Injections Assessed by VAS and sEMG. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- trigger point injection CI brief — competitive landscape report
- trigger point injection updates RSS · CI watch RSS
- Samsung Medical Center portfolio CI